openPR Logo
Press release

Rhabdomyosarcoma Market to Register Substantial Expansion by 2025

03-15-2018 09:24 AM CET | Health & Medicine

Press release from: Transparency Market Research

Rhabdomyosarcoma Market to Register Substantial Expansion

Rhabdomyosarcoma is a most common type of sarcoma in children that develops in body’s soft tissues, most commonly in muscles. It accounts around 3.5% of total childhood cancers. Sarcoma is cancer of connective tissue (cartilage or tendon), soft tissue (muscle), or bone. It can affect the neck, head, vagina, bladder, legs, arms, trunk, or any other body part. Children can develop rhabdomyosarcoma at any age; however, most of the cases have been recorded in children aged between 2 and 6 and in teens aged between 15 and 19. It is more common in boys than girls.

Exact disease cause is unknown; however, children suffering from inherited diseases such as pleuropulmonary blastoma, Costello syndrome, Li-Fraumeni syndrome, Noonan syndrome and neurofibromatosis type 1 are more susceptible to rhabdomyosarcoma. Moreover, children who were larger or had high birth weight have increased risk of developing rhabdomyosarcoma. Most common symptoms of rhabdomyosarcoma include bulging of eye, trouble in urination or bowel movements, headache, blood in urine, and bleeding in the throat, nose, vagina, or rectum.

Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=39539

The global Rhabdomyosarcoma Market can be segmented based on type, treatment, and region. In terms of type, the market can be categorized into embryonal rhabdomyosarcoma, alveolar rhabdomyosarcoma, and others. The others segment includes mixed type, pleomorphic/anaplastic, and spindle cell subtypes of rhabdomyosarcoma. The embryonal rhabdomyosarcoma segment is expected to be driven by high incidence rate. Approximately 4 per 1 million children (0-4 years of age) and 1.5 per 1 million adolescents are affected by embryonal rhabdomyosarcoma.

Based on treatment, the global rhabdomyosarcoma market can be classified into surgery, radiation therapy, chemotherapy, and others (stem cell therapy). Chemotherapy treatment generally involves a combination of various anti-neoplastic agents. The commonly used chemotherapeutic agents include dactinomycin, etoposide, irinotecan, ifosfamide, carboplatin, doxorubicin, and vincristine. Rise in incidence and prevalence of rhabdomyosarcoma, increased research and development expenditure, significant pipeline molecules (afatinib and temsirolimus), growing awareness among people are the factors that contribute to the growth of the market. However, high cost of treatment and associated side effects, disappointing result of promising pipeline molecules, and stringent government regulations are likely to hamper the growth of the market.

Request to View ToC of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=39539

Geographically, the global rhabdomyosarcoma market can be segmented into five major regions: North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America is anticipated to dominate the market, followed by Europe. High incidence of rhabdomyosarcoma (around 350 cases are diagnosed in the U.S. each year), growing awareness among people, increase in research and development expenditure, and well-established health care infrastructure contribute to the growth of the rhabdomyosarcoma market in North America. The market in Asia Pacific is anticipated to expand at a high CAGR during the forecast period, driven by India and China owing to increased government initiatives and developing health care infrastructure. The market in Latin America and Middle East & Africa is anticipated to grow during the forecast period owing to increase in investments by market players and rise in prevalence of rhabdomyosarcoma.

Leading players in the global rhabdomyosarcoma market include Eli Lilly and Company, Boehringer Ingelheim, Oasmia Pharmaceutical, Ovation Pharmaceuticals, Inc., and Pfizer.

View Report -

https://www.transparencymarketresearch.com/rhabdomyosarcoma-market.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rhabdomyosarcoma Market to Register Substantial Expansion by 2025 here

News-ID: 979319 • Views:

More Releases from Transparency Market Research

Handheld Marijuana Vaporizer Market Key Drivers, Market Research, and Insights for the USD 15.9 Bn Market 2022-2031
Handheld Marijuana Vaporizer Market Key Drivers, Market Research, and Insights f …
The global handheld marijuana vaporizer market has witnessed remarkable growth in recent years, attributed to the increasing acceptance of medicinal marijuana and the demand for convenient and discreet consumption methods. Valued at US$ 5 billion in 2021, the market is projected to surge at a CAGR of 13.4% to reach US$ 15.9 billion by 2031. This article delves into the factors driving this growth, the evolving market landscape, and the
Disinfectant Wipes Market Forecast 2020-2030 - Market Size, Drivers, Trends, And Competitors
Disinfectant Wipes Market Forecast 2020-2030 - Market Size, Drivers, Trends, And …
The COVID-19 pandemic has precipitated a remarkable surge in the demand for disinfectant products, with a notable emphasis on disinfectant wipes as an essential tool in maintaining hygiene and preventing the spread of pathogens. This research report delves into the multifaceted landscape of the disinfectant wipes market, elucidating key trends, drivers, and innovations shaping the industry. 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐫𝐞𝐩𝐨𝐫𝐭 @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=70359 Key Players and Market Developments Key players
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Study
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Stud …
The global 𝐭𝐢𝐬𝐬𝐮𝐞 𝐛𝐚𝐧𝐤𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭 reached a value of US$ 1,056.4 million in 2017 and is projected to nearly triple to US$ 2,903.3 million by 2026, with a robust Compound Annual Growth Rate (CAGR) of approximately 12.0% from 2018 to 2026. Factors such as increasing awareness about tissue donation, technological advancements, and a growing target patient population are anticipated to propel market growth during this period. Moreover, the market is expected
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
This report by Transparency Market Research, Inc. assesses the present state and future growth potential of the global 𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐜𝐥𝐨𝐬𝐮𝐫𝐞 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭. It features a comprehensive executive summary, offering insights into various segments of the market. Additionally, the report provides detailed analysis and data on product, access type, application, end user, and regional segments within the global market. Vascular closure devices is estimated to reach a value of ~US$ 1 Bn

All 5 Releases


More Releases for Rhabdomyosarcoma

Alveolar Rhabdomyosarcoma Treatment Market Projected to be Resilient by 2027
Alveolar Rhabdomyosarcoma Treatment Market research report is the new statistical data source added by CMI. According to this report, Alveolar Rhabdomyosarcoma Treatment Market research is an intelligence report with meticulous efforts undertaken to study the right and valuable information. The data which has been looked upon is done considering both, the existing top players and the upcoming competitors. Business strategies of the key players and the new entering market industries are
Alveolar Rhabdomyosarcoma Treatment Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Alveolar Rhabdomyosarcoma Treatment Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Alveolar Rhabdomyosarcoma Treatment players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Alveolar Rhabdomyosarcoma Treatment with respect
Rhabdomyosarcoma Therapeutics Analysis 2018 - Clinical Trials, Designations, Col …
According to the research findings, most of the drug candidates for the treatment of RMS are being developed to be administered by the intravenous route. The main advantage associated with the intravenous route is that the drug can easily be entered into the bloodstream, or lymph vessels, resulting in high bioavailability of the drug in the body and quick onset of action of drug. Explore report sample at: https://www.psmarketresearch.com/market-analysis/rms-therapeutics-pipeline-analysis/report-sample Several companies are
Rhabdomyosarcoma Market Size, Share - Industry Trend and Forecast 2017 - 2025
Marketresearchreports.biz has announced the addition of a new research study on the "Rhabdomyosarcoma Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025" to its report database. The objectives of this study are as follows: To define, describe, and forecast the "Rhabdomyosarcoma" market by type, application, component, delivery model, end user, and region To provide detailed information regarding major factors influencing market growth (drivers, restraints, opportunities, and industry-specific
Non Rhabdomyosarcoma Market : Emerging Industry Volume & Analysis 
Non-rhabdomyosarcoma is considered as soft tissue sarcomas that are mostly occurs in soft tissues: tendons, muscles, nerves, fatty tissues and fibrous tissues. Non-rhabdomyosarcoma can be observed in any pars of the body but mostly it occurs in arms and legs, the head and neck, the chest, abdomen and pelvis. Etiology for non-rhabdomyosarcoma is unknown but researchers found that there are some hereditary conditions which have a susceptibility to non-rhabdomyosarcoma. Possible
Rhabdomyosarcoma - Pipeline Review, H2 2017
“The Report Rhabdomyosarcoma - Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz” Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rhabdomyosarcoma - Pipeline Review, H2 2017, provides an overview of the Rhabdomyosarcoma (Oncology) pipeline landscape. Rhabdomyosarcoma (RMS) is a malignant tumor of connective tissue in which abnormal cells are thought to arise from primitive muscle cells. Symptoms